| RS757170859 |
DOCK6
|
Health Risk |
Likely pathogenic |
DOCK6-related disorder, DOCK6-related disorder |
| RS757171524 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS757172838 |
F13A1
|
Health Risk |
Likely pathogenic |
Factor XIII, A subunit |
| RS757172850 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Transitory neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS757173009 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS757173108 |
DNMT3A
|
Health Risk |
Conflicting classifications of pathogenicity |
DNMT3A-related disorder, Tatton-Brown-Rahman overgrowth syndrome |
| RS757173567 |
COQ4
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Developmental disorder |
| RS757174356 |
TUB
|
Health Risk |
Conflicting classifications of pathogenicity |
TUB-related disorder, TUB-related disorder |
| RS757175092 |
SLC34A2
|
Health Risk |
Pathogenic |
— |
| RS757175768 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS757175860 |
HOXD13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757175933 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS757177003 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS757177279 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type II, Citrin deficiency |
| RS757177349 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS757177445 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Macrocephaly-autism syndrome |
| RS757178659 |
UROD
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial porphyria cutanea tarda, Familial porphyria cutanea tarda |
| RS757178741 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS757179309 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS757179911 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS757183814 |
ZMIZ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS757184166 |
BRCA1
|
Health Risk |
Likely pathogenic |
— |
| RS757184514 |
MTRR
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorders of Intracellular Cobalamin Metabolism, Methylcobalamin deficiency type cblE |
| RS757185314 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS757187481 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS757188030 |
SLFN14
|
Health Risk |
Pathogenic |
Platelet-type bleeding disorder 20, Platelet-type bleeding disorder 20 |
| RS757188953 |
OTOG
|
Health Risk |
Pathogenic |
Monogenic hearing loss, Monogenic hearing loss |
| RS75718910 |
RNASEH2A
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi Goutieres syndrome |
| RS757189400 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS757190258 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS757191246 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Transitory neonatal diabetes mellitus |
| RS757191914 |
HELLS
|
Health Risk |
Pathogenic |
— |
| RS757192342 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS757192357 |
TUBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757192472 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS757193884 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS757194485 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS757194881 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypobetalipoproteinemia, Familial hypercholesterolemia |
| RS757195322 |
MYH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, proximal |
| RS757195926 |
LARS1
|
Health Risk |
Likely pathogenic |
— |
| RS757197161 |
METTL23
|
Health Risk |
Likely pathogenic |
— |
| RS757197196 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
RAI1-related disorder, RAI1-related disorder |
| RS757197845 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS757198328 |
ADAMTSL4
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS757198475 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS757198557 |
CLCN7
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant osteopetrosis 2, Hypopigmentation |
| RS757198941 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS757200738 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS757200771 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757201043 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS75720127 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS757202895 |
XPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Basal ganglia calcification, idiopathic |
| RS757203330 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757203783 |
TBK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS757204134 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia 15 |
| RS757204749 |
TMEM67
|
Health Risk |
Likely pathogenic |
COACH syndrome 1, COACH syndrome 1 |
| RS757204777 |
LARS2
|
Health Risk |
Likely pathogenic |
Inborn mitochondrial myopathy, Inborn mitochondrial myopathy |
| RS757205195 |
ATAD3A
|
Health Risk |
Likely pathogenic |
— |
| RS757205958 |
CPS1
|
Health Risk |
Pathogenic |
— |
| RS757206151 |
CPLANE1
|
Health Risk |
Likely pathogenic |
— |
| RS757206516 |
CFAP418
|
Health Risk |
Pathogenic |
— |
| RS757207387 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS757208121 |
CC2D2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS757208743 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, 6 conditions |
| RS757209071 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal pseudo-hydrocephalic progeroid syndrome, Leukodystrophy |
| RS757210438 |
CEP290
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 14, Bardet-Biedl syndrome 14 |
| RS757210594 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS757211048 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized juvenile polyposis/juvenile polyposis coli, Hereditary cancer-predisposing syndrome |
| RS757211186 |
SLC24A1
|
Health Risk |
Pathogenic |
— |
| RS757211277 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS757211531 |
FANCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group L, Fanconi anemia |
| RS757212818 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS757212984 |
SQSTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Paget disease of bone 2, early-onset |
| RS757213764 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS757215211 |
COL11A2
|
Health Risk |
Likely pathogenic |
COL11A2-related disorder, COL11A2-related disorder |
| RS757215216 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS757215612 |
RAPSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS757216362 |
REST
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS757216434 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS757216544 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Familial thoracic aortic aneurysm and aortic dissection |
| RS757218098 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Febrile seizures, familial |
| RS757218186 |
SLC17A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Salla disease, Inborn genetic diseases |
| RS757218786 |
HIVEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS757219498 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS75722024 |
LRIT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1F, Inborn genetic diseases |
| RS757220593 |
C2CD3
|
Health Risk |
Conflicting classifications of pathogenicity |
C2CD3-related disorder, C2CD3-related disorder |
| RS757221445 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS757221938 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS757222354 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS757222534 |
INPP5E
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome |
| RS757222815 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS757222949 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS757224600 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, KANSL1-related disorder |
| RS757224692 |
ALOX12B
|
Health Risk |
Pathogenic |
— |
| RS757225144 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS757225917 |
LHCGR
|
Health Risk |
Pathogenic |
Gonadotropin-independent familial sexual precocity, Leydig cell agenesis |
| RS757227515 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS757228029 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS757229467 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757230162 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |